UB spinoff Cytocybernetics receives funding to accelerate COVID-19 drug screening
University at BuffaloUniversity at Buffalo spinoff Cytocybernetics is developing a high-tech tool called CyberQ to rapidly assess whether or not investigational COVID-19 drugs have arrhythmogenic properties that can result in sudden cardiac death.